Universal assay of vitellogenin as a biomarker for environmental estrogens. by Heppell, S A et al.
Universal Assay ofVitellogenin as a Biomarker
for Environmental Estrogens
Scott A. Heppell,1 Nancy D. Denslow,2 Leroy C. Folmar,3 and
Craig V. Sullivan'
'Department ofZoology, North Carolina State University, Raleigh, North Carolina; 2Department of
Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida; 3U.S. Environmental Protection
Agency, Gulf Breeze, Florida
Vitellogenin (VTG), the serum phospholipoglycoprotein precursor to egg yolk, is potentially an ideal biomarker for environmental estrogens. This
study was undertaken to develop antibodies against conserved regions on the VTG molecule that could form the basis for establishing bioassays to
detect estrogen exposure in any oviparous vertebrate. We developed monoclonal antibodies (mAbs) generated against purified rainbow trout
(Oncorhynchus mykiss) VTG and selected for the property of specifically recognizing VTG purified from two phylogenetically distant vertebrates,
trout and striped bass (Morone saxatilis). Results of enzyme-linked immunosorbent assay and Western blotting indicated that these mAbs
specifically recognize purified VTG and VTG or other estrogen-inducible proteins in plasma or serum from representative species of four vertebrate
classes (fish, amphibians, reptiles, and birds). All of the mAbs generated were IgM class. A polyclonal antiserum was raised against a synthetic
consensus peptide representing the conserved N-terminal amino acid sequence of VTG. The results of Western blotting indicate that this antiserum
specifically recognizes VTG in plasma or serum from teleost fish of diverse families. It was used to detect VrG in Western blots of serum from
brown bullhead (Ameiurus nebulosus) with cancer (hepatocellular and cholangio-carcinoma) collected from a contaminated industrial site outside of
their normal vitellogenic season. Our results indicate that it is feasible to generate antibodies capable of recognizing VTG without regard to species
and that development of a universal VTG assay is an achievable goal. - Environ Health Perspect 103(Suppl 7):9-15 (1995)
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Introduction
Environmental estrogens, chemicals with
bioactivity similar to endogenous estrogen,
are known to affect development and sexual
maturation of vertebrates and are impli-
cated as cancer promoters (1). They
indude breakdown products of detergents,
pesticides, plasticizers, and avariety ofchlo-
rinated compounds. Ideally, such chemicals
would be evaluated for estrogenicity before
their use or release into the environment.
However, their notoriously weak struc-
ture-activity relationship requires that the
identity and potency of environmental
estrogens be defined by bioactivity. The
current lack ofeffective bioassays is consid-
ered to be a proximal cause of the lack of
regulatory action regarding these com-
pounds (2). An effective bioassay needs to
be developed to assess the estrogenicity of
synthetic compounds or their derivatives
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and their potential effects on the reproduc-
tive biology ofvertebrates.
Vitellogenin (VTG) is potentially an
ideal biomarker for the estrogenicity of
chemicals. It is a large serum phospholipo-
glycoprotein that serves as the major pre-
cursor to the egg-yolk proteins of
oviparous vertebrates (3). VTG is synthe-
sized and secreted by the liver in response
to circulating estrogens in maturing
females (4,5) and is normally undetectable
in the plasma of immature animals and
males. The presence of this estrogen-
inducible protein in the serum of an ani-
mal can be taken as evidence ofexposure to
endogenous or exogenous estrogens or
estrogen mimics. This potential ofVTG as
a biomarker has already been explored
using several fish species, forwhich both in
vivo and in vitro assays have been devel-
oped (6-10). However, immunological
and structural properties ofVTG can vary
greatly even among closely related species
(11-14), which limits broad scale applica-
tion ofthese assays acrossvertebrate taxa.
Recently it has become apparent that
VTG is an ancient protein belonging to a
multigene family that includes a variety of
lipoproteins, including various vertebrate
and invertebrate VTGs as well as the
human serum proteins, apolipoprotein
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B-100 and von Willebrand factor (15-18).
Coupled with prior evidence for conserva-
tion of some functional and immunologi-
cal properties of the molecule (19-22),
these findings suggest that VTG may pos-
sess conserved epitopes that could be
exploited to develop antibodies and
immunoassays ofa more universal nature.
This study was undertaken to develop
antibodies against conserved regions on the
VTG molecule that could form the basis
for establishing bioassays to detect estrogen
exposure in any oviparous vertebrate. We
attempted to develop both monoclonal
antibodies generated against purified VTG
and polyclonal antisera raised against the
conserved N-terminal amino acid sequence
ofVTG (23). Using these two approaches
we demonstrated that it is feasible to gener-
ate antibodies capable ofrecognizing VTG
without regard to species oforigin and that
development of a universal VTG assay is
an achievable goal.
Methods
Balb/C mice were immunized ip with
either 100 pg of rainbow trout
(Oncorynchus mykiss) VTG purified as
described by Hara et al. (24) or 100 pg of
striped bass (Morone saxatilis) VTG
purified as described by Tao et al. (25)
mixed 1:2 with Freund's complete adju-
vant. Mice were boosted twice at 2- to 3-
week intervals with 50 pg ofantigen mixed
1:2 with Freund's incomplete adjuvant.
Four days before fusion, they were again
boosted with 100 pg of antigen in incom-
plete adjuvant. Monoclonal antibodies
(mAbs) were then generated using standard
methods (26). This entire procedure was
replicated 3 times. In an attempt to induce
antibody class shift and increase the affinity
of the antibodies, the final set of immu-
nizations was modified by increasing the
time between boosts to a minimum of 3
weeks and incorporating a third boost
prior to fusion.
Hybridoma colonies were screened for
VTG cross-reactivity using an antibody
capture enzyme-linked immunosorbent
assay (ELISA) (27) against purified VTGs,
blood plasma from immature or male
striped bass and trout injected with 170-
estradiol (E2) to induce vitellogenesis (E2-
plasma) (15), or plasma from normal male
bass and trout as the reference prepara-
tions. The mAbs were harvested by collect-
ing the tissue culture supernatant (TCSN),
which was stored at 40C in the presence of
0.01% NaN3 for up to 3 months until use.
TCSN (100 pl) was mixed 1:2 with 10%
normal goat serum and added to the wells
ofa 96-well plate that had been previously
coated with antigen. The second antibody
was a goat antimouse IgM, p-chain specific
antibody (Sigma Chemical Co, St. Louis,
MO) conjugated to horseradish peroxidase,
and antibody binding was visualized with
O-phenylenediamine/H202 in 0.1 M cit-
rate-phosphate buffer, pH 5.0.
Hybridoma colonies whose TCSN
demonstrated immunoreactivity in the
ELISA to VTG and E2-plasma from both
bass and trout but did not react to normal
male plasma were selected for cloning.
Rainbow trout and striped bass were cho-
sen as the species for initial screenings
because they represent distinct vertebrate
lines that have evolved independently over
a considerable period of time (-200x 106
years), methods for purifying their respec-
tive VTGs were well established (24,25),
and they were available because they were
subjects of other endocrine investigations
in our laboratory. Positive colonies were
subjected to limiting dilution to produce
monoclonal cell lines secreting mAbs with
desired characteristics. The mAbs from the
monoclonal cultures were isotyped using
commercial kits (Life Technologies,
Gaithersberg, MD, or Sigma).
Western blots were used for a second
series of mAb screens. Samples of purified
VTG, E2-plasma, or male plasma from
trout and bass were normalized for protein
concentration, separated by sodium dode-
cyl sulfate 4 to 15% polyacrylamide gradi-
ent gel electrophoresis (SDS-PAGE) on a
PhastSystem electrophoresis apparatus
(Pharmacia, Piscataway, NJ) and then elec-
troblotted onto Immobilon-P PVDF
membranes (Millipore, Marlborough, MA)
using the PhastSystem immunoblot appa-
ratus (25). Membranes were blocked in
phosphate-buffered saline (PBS) (0.01 M
Na.H.PO4, 0.15 M NaCl, pH 7.3) with
3% bovine serum albumin overnight, incu-
bated with TCSN diluted in PBS with
0.5% Tween-20 (wash buffer; range
1:3-1:10, v/v) for 2 hr, and then probed
with secondary antibody (1:4000 in wash
buffer) and avidin-biotin complex in wash
buffer (ABC Elite Kit, Vector Laboratories,
Burlingame, CA) for 30 min each.
Antibody binding was visualized with
diaminobenzidene (DAB Kit, Vector
Laboratories).
Preliminary ELISA and Western blot
screens ofthe ability ofthe mAbs to differ-
entially bind to vitellogenic plasma and
nonvitellogenic plasma from a variety of
other species were also done. Additional
species tested by ELISA included several
fishes (white perch, Morone americana;
white croaker, Genyonemus lineatus; brown
trout, Salmo trutta; and pollock, Theragra
chalcogramma) as well as representative rep-
tiles (tuatara, Sphenodonpunctatus; and rat-
tlesnake, Crotalus molossus) and a bird
(chicken, Gallus domesticus). Additional
species screened by Western blot included
the bullfrog (Rana catesbeiana), the black
rat snake (Elapheobsoleta), and the chicken.
To initiate generation of polyclonal
antisera against known conserved regions
on the VTG molecule, we microsequenced
amino acids in the N-terminal regions ofa
number ofVTGs purified from several phy-
logenetically diverse teleost fish (23). We
obtained sequences for several teleost fish
induding the striped bass, brown bullhead
(Ameiurus nebulosus), pinfish (Lagodon
rhomboides), yellow perch (Percaflavescens),
and medaka (Oryzias latipes), as well as
sequences deduced from the cDNA of
mummichog (Fundulus heteroclitus) and
white sturgeon (Acipenser transmontanus).
The striped bass was used as the template
for comparison because it is the mosthighly
evolved fish in our study. To determine an
optimal peptide segment for antibody tar-
geting, we analyzed a consensus N-terminal
sequence with a protein structure program
(28), which provides an antigenicity index
at each position of the peptide. Using this
information we designed a consensus
peptide fifteen amino acids long.
The consensus peptide was assembled
on a Model 431A automated peptide syn-
thesizer (Applied Biosystems, Foster City,
CA) from the C-terminus towards the N-
terminus with the a-carboxyl group of the
amino acid attached to the solid support,
using Rink resin and 9-fluorenylmethoxy-
carbonyl (FMOC) protected amino acids.
An additional Cys residue was added at the
N-terminus for coupling the peptide to acti-
vated carrier proteins (29). The peptide was
cleaved from the resin with trifluoroacetic
acid (TFA) (30), purified by reverse-phase
high performance liquid chromatography
(rpHPLC) on a Whatman partisil 10
ODS-2 column fitted to an HPLC system
(Waters, Milford, MA) and equilibrated
with 20% solvent A (0.1% TFA in
CH3CN) and 80% solvent B (0.1% TFA in
dH20) followedbya 20-min lineargradient
to 35% solventA at aflow rate of 1 ml/min.
Compositional and quantitative analysis of
the peptide was conducted on a Pico Tag
work station (Waters) after a 22-hr hydroly-
sis and phenyl isothiocynate (PITC)
derivitization (31).
Aliquots of purified peptide (2 mg)
were conjugated (1:2, w/w) to maleimide-
activated carrier proteins, keyhole limpet
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hemocyanin (KLH; mw 450-13,000
kDa), or ovalbumin (OVA; mw 45 kDa)
using an Imject Activated Immunogen
Conjugation kit (Pierce Chemical Co.,
Rockford, IL). The KLH peptide conju-
gate was used to immunize two female
New Zealand white rabbits sc with 200 pg
protein in 0.5 ml sterile distilled water
mixed 1:2 with Freund's complete adju-
vant. Subsequent immunizations (n= 8),
done 2 weeks later and then at approxi-
mately 3- to 4-week intervals, used 100 pg
protein and Freund's incomplete adjuvant.
Rabbits were bled periodically through the
marginal ear vein and serum samples were
collected, diluted 1:100 in ELISA buffer,
and evaluated for antibody titers using the
ELISAwith the OVA-peptide conjugate as
the reference protein. When the titer was
judged to be sufficient, the rabbits were
exsanguinated and their serum was iso-
lated and frozen at -80°C until use.
Purified VTGs and serum samples
obtained from striped bass males or E2-
treated females were separated by SDS-
PAGE (32) and Western blots (33) were
used to test the immunoreactivity of the
antisera to the VTGs and other serum pro-
teins. Western blots used the antiserum
diluted 1:3000 and were visualized using
goat anti-rabbit IgG conjugated to alkaline
phosphatase as the secondary antibody.
Results
MonodonalAntibodies
Three sets offusions resulted in the genera-
tion ofseven mAb cultures. The first set of
fusions gave rise to two hybridoma lines
from which one monoclonal culture was
developed. The mAb produced by this cul-
ture, designated Rl, was isotyped as an
IgM class antibody with kappa light
chains. RI demonstrated strong cross reac-
tivity to VTG from striped bass and rain-
bow trout in the ELISA and was used to
develop the Western blot procedure. Initial
ELISA screens that reacted RI with plasma
from vitellogenic females or males of sev-
eral vertebrate species from diverse taxa
showed specific reactivity to vitellogenic
plasma for all species tested. Rl was lost
due to an equipment malfunction. The
second set of fusions resulted in one mAb
designated T2, but T2 lost specific
immunoactivity to vitellogenic plasma
samples or VTGs shortly after its develop-
ment, and it was never isotyped or used for
screening. The third set offusions resulted
in one positive hybridoma colony from
which five monoclonal cultures were
derived. The mAbs produced by these
cultures were designated 2C1 1, 2D8, 3E8,
5G7, and 8G7. All five were isotyped as
IgMs. Because 2D8 gave the most consis-
tent results in initial screens, it was chosen
for use in subsequent analyses. All of the
hybridoma cultures that were cloned were
derived from mice immunized with trout
VTG. None of the hybridoma colonies
derived from mice immunized with bass
VTG gave significant levels of cross-reac-
tivity to both trout and bass VTG, the
criterion used to select colonies for doning.
The Rl mAb showed an excellent
dose-response profile of binding to VTG
purified from trout and bass and showed
very low levels ofreactivity to male plasma
from both species (Figure 1). When the
ELISAwas used to screen plasma from nat-
urally vitellogenic female or male white
perch, white croaker, brown trout, pollock,
snake, tuatara, and chicken, the reactivity
ofRI to female plasma was a minimum of
2 to 3 times higher than to male plasma
(Table 1). 2D8 immunoactivity in the
ELISA to plasma from vitellogenic and
nonvitellogenic striped bass was similar to
that of Rl but exhibited substantially
higher background levels (Figure 2).
Similar results were obtained for trout
plasma and a variety of purified control
proteins including OVA, bovine serum
albumin, and KLH, which gave the same
profile as male trout or bass plasma over
the same range of total protein concentra-
tion (data not shown). The higher back-
ground for 2D8 was not accompanied by
any detectable nonspecific binding to
plasma proteins from nonvitellogenic bass
or trout in Western blots. The 2D8 mAb
was also screened by ELISA against plasma
from vitellogenic and nonvitellogenic black
rat snakes with similar results (Figure 3).
SDS-PAGE of purified trout or bass
VTG or plasma samples from fish injected
0.6 -
0.5 -
0.4 -
3 0.3-
0
0.2 -
0.1 -
0.001
-U- RBTVTG
-o- SBVTG
--- RBT Male
-+- SB Male
Table 1. Reactivity in the antibodycapture ELISA ofthe
Rl monoclonal antibody (OD 490) to plasma samples
from vitellogenic females and males of several verte-
brate species. Plasma sampleswere diluted 1:100.
Plasma source Female Male
Brown trout, 1.613 0.163
Salmo trutta
Pollock, 0.768 0.213
Theragrachalcogramma
White croaker, 0.745 0.219
Genyonemus lineatus
White perch, 1.123 0.143
Moroneamericana
Tuatara, 0.473 0.160
Sphenodonpunctatus
Snake, 0.492 0.107
Crotalusmolossus
Chicken, 0.464 0.186
Gallusdomesticus
0.7- VTG
0.6 -._ Control
0.5-
0.4-
o 0.3e
0.2 \
0.1 0
0.0- X
1 2 o3 4 5 6
Log, plasma dilution
Figure 2. Binding of the 2D8 monoclonal antibody to
serial dilutions of plasma from vitellogenic (VTG) and
nonvitellogenic (control) immature striped bass in the
antibody capture ELISA. Vitellogenesis was induced in
the fish by injection with E2. Note that even with high
background levels for nonvitellogenic fish there is still
a distinct increase in binding to plasma from E2-
treated fish.
0.4-
0.3-
° 0.2-
0.1-
0.01 0.1 1 10 100
VTG, ig/ml
Figure 1. Binding of the Rl monoclonal antibody (OD
490) to purified striped bass (SB) and rainbow trout
(RBT) VTG in the antibody capture ELISA. Dilutions of
male plasma (RBT male and SB male) are serial from
1:10 to 1:1280(scale notshown).
VTG
- C- Control
4 5
Log, plasma dilution
6
Figure 3. Binding of the 2D8 monoclonal antibody to
serial dilutions of plasma from vitellogenic (VTG) and
nonvitellogenic (control) black rat snakes in the anti-
body capture ELISA. Vitellogenesis was induced in the
snakes by injection with E2.
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with E2 revealed distinct high molecular
weight bands (MA 170,000-200,000) not
present in plasma from male trout or bass
(Figure 4A). We identified these bands as
the primary VTG subunit and its degrada-
tion products (24,25,34). Western blots of
the SDS-PAGE gels done using the 2D8
mAb revealed immunoreactivity to the
purified VTGs and the high molecular
weight bands for VTG in plasma, but no
binding to plasma proteins from male trout
or bass was detected (Figure 4B). This pat-
tern in SDS-PAGE and Western blots is
identical to that obtained using homolo-
gous antisera raised in rabbits against
purified trout or bass VTG [(24,25,34); A
Hara and CV Sullivan, unpublished data]
with the exception that the homologous
antisera reacted only very weakly with the
heterologous VTG, producing a barely vis-
ible band in Western blots (35). SDS-
PAGE and Western blots using the 2D8
mAb and plasma from E2-treated and con-
trol bullfrogs, black rat snakes, and chick-
ens also showed immunoreactivity to high
molecular weight, E2-inducible proteins,
presumably VTG, but not to plasma pro-
teins in control samples (data not shown).
Negative controls for the Western blots a
involved using fresh culture media in place
of TCSN from the monoclonal cell cul-
tures producing the 2D8 mAb or substitut- 20
ing TCSN from a monoclonal culture
producing an IgM class mAb directed
against a recombinant hepatitis B core anti-
gen. These substitutions eliminated
immunoreactivity on theWestern blots. 9
Polyonal Antisera
The results of microsequencing of the fish 69.l.
VTGs verified the strong degree ofconser-
vation at the N-terminal region ofthe pro-
tein (Table 2). The region of highest
homology among the fishes extends 46-:
between amino acid residues 7 and 20 of
the striped bass VTG molecule, showing
100% identity in sequence with mummi-
chog VTG, 87% with pinfish VTG, 93% Figure 5. SD
with brown bullhead VTG, and 60% with of plasma fr
white sturgeon VTG. This degree of peptideantis
homology made the N-terminus a primary from an imm
candidate for generating an antipeptide of b; /ane e
antiserum for detecting VTG in a wide bars indicate
variety ofspecies (23).
The antiserum generated against the
consensus N-terminal VTG sequence historically
conjugated to KLH reacted preferentially clear arom
with the VTG band (Mr=: 170,000) in an associ
Western blots of plasma from immature apparent
striped bass injected with E2; this band is tumor-be;
not visible in SDS-PAGE or Western blots after SDS
of plasma from control male bass (Figure adult fema
5). The fainter immunoreactive band trol creek
(Mr 36,000) visible on the Western blot the norm
only in the lane for male plasma appears to species (Fi
have a lower affinity to the antiserum, fad- blots don
ing more rapidly as the antiserum is diluted antiserum
out. We are in the process ofpurifying and ity to the
identifying this protein. the lane f4
We previously reported on selective female an
induction ofvitellogenesis in tumor-bear- presumabl
ing (hepatocellular- and cholangio-carcino- (Figure 7)
mas) male and female brown bullhead evident is
collected from the Black River near control ma
Lorraine, Ohio (23). The collection site We ar
receives effluent from a steel plant and ofcross-re
Table2. N-terminal amino acid sequences for several fish vitellogenins.
b c d e
)S-PAGE and corresponding Western blots
om striped bass done using the anti-VIG
;erum. Lane a, mw markers; lane b, plasma
ature striped bass injected with E2; lane c,
a male striped bass; lane d, Western blot
Western blot of c. Numbers with horizontal
the mass ofthe mw markers.
y received effluent rich in polynu-
natic hydrocarbons (PAHs) from
iated coking facility. VTG is
in serum samples from the
aring adult males and females
;-PAGE, but not in serum from
ales collected from a pristine con-
at the same time and outside of
al vitellogenic season for this
igure 6). Corresponding Western
e using the anti-VTG peptide
revealed strong immunoreactiv-
VTG band (Mr- 170,000) in
or plasma from a tumor-bearing
d also to a lower Mr band that is
ly a breakdown product ofVTG
). This immunostaining was not
n the lane for plasma from a
ale.
e currently examining the extent
activity ofthe anti-VTG peptide
Figure 4. (A) SDS-PAGE of rainbow trout and striped
bass VTG and blood plasma proteins. Lane a, purified
striped bass VTG; lane b, plasma from striped bass
injected with E2; lane c, male striped bass plasma;
lane d, purified rainbow troutVTG; lane e, plasma from
rainbow trout injected with E2; lane f, male rainbow
trout plasma. The gels were stained with Coomassie
Brilliant Blue. (B) Western blots of a parallel set of the
same samples shown in A done using the 2D8 mono-
clonal antibody.
Source Sequence Homology, %
Striped bass: HNVNFAPEFAAGKTYVYKYEAL (100)
Mummichog: MKAVVLALTLASYA -GONFAPEFAAGKTYVYKYEAL (100)
Pinfish: YQVNLAPEFAAGR_THVYKYEAF (87)
Bullhead: HQJILVPEFAAGKTFVYKYE (93)
Yellow perch: QVNFAPEFA
Medaka: QLVFAPEFA
Sturgeon: QQTKYEPSFSGSKTYOYKYEG (60)
Underlining indicates regions ofsimilarity with the striped bass. Numbers in parentheses are the percent similarity
with the striped bass sequence between positions 7 and 20. The sequence MKAWLALTLASYA for mummichog is
the putative leader sequence (23).
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200-i
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468-
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21.5-
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Figure 6. SDS-PAGE of mw marker proteins or serum
from brown bullhead. Lane a, mw markers; lane b,
serum from a female collected from a pristine control
creek; lane c, serum from a female with hepatocellu-
lar- and cholangio-carcinoma collected from the pol-
luted Black River; lane d, serum from a male with
cholangio-carcinoma collected from the Black River.
Numbers with horizontal bars indicate the mass ofthe
mw markers.
antiserum with plasma from other fish
species. Initial studies indicate that the
antiserum may have wide cross-reactivity
with VTGs from several teleost fish includ-
ing medaka (Mr.- 193,000 and 130,000)
and yellow perch (Mr ' 120,000 and
104,000). The fish VTGs tested so far all
share a high degree ofsimilarity at their N-
termini (Table 2); however, a preliminary
test with rainbow trout serum gave nega-
tive results. Further work is in progress
with this species and others that fill the
phylogenetic gap between rainbow trout
and striped bass.
Discussion
There is a demonstrable need for a bio-
chemical marker that can be used to iden-
tify estrogenic compounds before their
release into the environment (36). The
results of this study generally corroborate
prior reports on VTG as a biomarker for
exposure to estrogens (6-9), and they
demonstrate the feasibility of two
approaches to developing antibodies with
Figure 7. SDS-PAGE (lanes a-c) and corresponding
Western blots (lanes dand e) of mw marker proteins or
serum from brown bullhead using the anti-VTG peptide
antiserum. Lane a, mw markers; lane b, serum from a
female with hepatocellular- and cholangio-carcinoma
collected from the polluted Black River; lane c, serum
from a male collected from a pristine control creek;
lane d, Western blot of b; lane e, Western blot of c.
Numbers with horizontal bars indicate the mass of the
mw markers.
the property of recognizing vertebrate
VTG without regard to species of origin.
We developed both monoclonal antibodies
and a polyclonal antiserum possessing this
property. Such antibodies have the poten-
tial to form the basis of a universal VTG
immunoassay able to detect estrogen
exposure in anyoviparous vertebrate.
Our ELISA results for the mAbs (RI
and 2D8) show much higher absorbance
values for purified VTG or plasma from
E2-treated fish or snakes than for plasma
from untreated immature animals or males
(Figures 1-3), but they do not provide
conclusive evidence that the mAbs
specifically react to VTG in the plasma.
However, the results of Western blotting
clearly demonstrate that the 2D8 mAb
binds preferentially to VTG in plasma of
rainbow trout and striped bass (Figure 4)
as well as to high MW E2-induced pro-
teins, presumably VTG, in plasma ofbull-
frogs, black rat snakes, and chickens (35).
Combined with the ELISA results, these
observations indicate that the 2D8 mAb
specifically reacts to purified VTG and pos-
sibly other estrogen-inducible proteins in
representatives of at least four vertebrate
classes. Because the monoclonal cell line
producing 2D8 was initially selected on the
basis of its ability to recognize VTG from
both trout and bass, species from lineages
that have evolved independently for
approximately 200 million years, we con-
sider it likely that 2D8 is targeted at a con-
served epitope on the VTG molecule.
Whether this epitope is completely unique
to VTG remains to be rigorouslyverified.
All ofthe mAbs that we developed were
found to be IgM class antibodies. Such
antibodies, while having strong epitope
specificity, have a tendency toward high
levels ofnonspecific binding in immunoas-
says because of their large mass. This is
likely to be a factor in the relatively high
background seen in our ELISA (Figure 2).
We plan to cleave the pentameric IgM into
its monomeric Fab fragments in an
attempt to reduce the high background. In
our final series of immunizations, we
modified our protocol to increase the prob-
ability ofgenerating high affinity-high titer
IgG mAbs but we were unable to accom-
plish this goal. The last five monoclonal
cultures, derived from the final fusion, all
produced IgM class mAbs.
IgM induction is part of the initial
immune response following exposure to a
novel antigen and, upon subsequent expo-
sure to the same antigen, there is typically a
class shift towards synthesis of IgGs (26).
We have developed the concept that our
inability to induce antibody class shift and
generate an IgG mAb may be a function of
the degree or nature ofantigenicity ofcon-
served epitopes on the VTG molecule.
Because there are extensive gene sequences
that are well conserved between VTG and
some mammalian serum proteins (16,17),
some of which are also estrogen inducible
(37), it is possible that there is no antibody
class shift due to lack ofstrong antigenicity
ofthe conserved VTG epitopes. They may
be too close to "self' to generate an IgG
response. There are natural autoantibodies
present in most healthy individuals; in
mice, the vast majority of these are IgM
class (38).
It should also be noted that VTG is a
large and complex phospholipoglycopro-
tein, one that in our hands has proved to
be highly antigenic (24,25). There is no
reason to presume that dominant epitopes
on the protein are conserved. Polyclonal
antisera raised in rabbits against trout or
bass VTG show very high levels of
immunoreactivity to their homologous
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VTG but are also weakly reactive to het-
erologous VTG from the other species
(35), lending credence to the concept that
conserved epitopes contribute little to the
overall immune response to VTG. During
development of the mouse immune
response, manyVTG epitopes maybe anti-
genic enough to induce IgG synthesis,
whereas the conserved epitopes we select
for may not exhibit this degree of anti-
genicity. We are currently exploring this
possibility using denatured and delipidated
or deglycosylated VTG as the antigen for
generating universal mAbs. Alternatively,
we will attempt to suppress the immune
response of mice to species-specific
immunodominant VTG epitopes by
treatment with cyclophosphamide (39).
It is interesting to note that although
both trout and bass VTGs were used as
antigens, wewere only able to obtain mAbs
with the desired specific cross-reactivity
from mice immunized with trout VTG.
The bass VTG was however able to gener-
ate an immune response in mice, which
lead to production of numerous hybrid-
oma colonies secreting antibodies specific
to bass but not trout VTG. Salmonids are
considered primitive to the temperate
basses, and perhaps the conserved struc-
tural epitope that our mAbs were directed
against is less variable or less protected in
these fish. This may account for the better
immune response that trout VTG elicited
in mice as compared to striped bass VTG.
Our polyclonal antiserum directed
against the short, synthetic, consensus N-
terminal sequence of VTG (Table 2)
appears to specifically recognize the high
molecular weight, E2-inducible protein that
we identified as VTG in plasma from
female or E2-treated fish (Figures 5,6) and
serum from fish with cancer (hepatocellu-
lar- and cholangio-carcinoma) collected
from a contaminated site (Figure 7). The
faint protein band (-36 kDa) visible in
Western blots of striped bass plasma may
be a VTG-related protein. Once we have
purified, sequenced, and identified this pro-
tein, we will be able to more conclusively
evaluate the reason(s) for its cross-reactivity
to the anti-VTG peptide antiserum.
Although the cross-reactivity may preclude
utilization of this antiserum in ELISA
screens for VTG in some species, the anti-
serum is clearly useful for Western blotting
to detect VTG in diverse lineages offishes.
In summary, we have demonstrated the
feasibility of generating universal antibod-
ies directed against the VTG molecule-
antibodies that can be exploited to detect
VTG as a general biomarker for exposure
of oviparous animals to endogenous and
environmental estrogens and estrogen
mimics. Both mAbs directed against con-
served epitopes on the protein and a poly-
clonal antiserum directed against its
conserved N-terminal amino acid sequence
were developed. Further research is needed
to produce higher affinity mAbs and more
specific antisera to more easily develop
bioassays for VTG as a biochemical marker
for estrogen exposure. Our results clearly
indicate that this is an achievable goal.
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